【大紀元2013年06月19日訊】(大紀元記者徐翠玲台灣台北報導)乳癌患者又多了一項選擇,衛生署5月核准標靶藥物口服哺乳動物雷帕黴素靶蛋白(mammalian Target of Rapamycin, mTOR)抑制劑,不只副作用小,也可提升生活品質。長庚醫院一般外科及乳房外科主任陳訓徹19日指出,停經後且為ER+/HER2-的晚期乳癌患者,使用口服mTOR抑制劑加上芳香環酶抑制劑治療,存活期可由4.1個月延長到11個月,等於延長2倍以上存活期。
美東時間: 2013-06-19 10:30:02 AM 【萬年曆】 本文網址: http://www.epochtimes.com/b5/13/6/19/n3897872.htm新標靶藥物mTOR-乳癌患者見曙光.html
This entry passed through the Full-Text RSS service — if this is your content and you're reading it on someone else's site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers. Five Filters recommends: 'You Say What You Like, Because They Like What You Say' - http://www.medialens.org/index.php/alerts/alert-archive/alerts-2013/731-you-say-what-you-like-because-they-like-what-you-say.html
You are receiving this email because you subscribed to this feed at blogtrottr.com.